Potential Under-Recognised Risk of Harm from Prescribing Propranolol

Propranolol is widely prescribed across primary care, yet emerging evidence has highlighted the potential for serious harm in some patient groups. This webinar will raise awareness of the under-recognised risks associated with propranolol prescribing, particularly in patients with co-existing anxiety, depression or migraine. Drawing on findings from a recent prescribing review, the session will explore prescribing trends, overdose risk, patient safety considerations, and practical strategies to support safer prescribing and monitoring.

By attending this webinar you will:

• Understand the potential risks associated with propranolol prescribing.
• Recognise patients who may be at greater risk of harm from propranolol